julianna lisziewicz born hungarian immunologist lisziewicz headed many research teams discovered produced immunotheraputic drugs treat diseases like cancer chronic infections like hivaids drugs successfully used clinical trials lisziewicz graduated budapest university technology budapest hungary msc chemistry biology went earn phd molecular biology maxplanck institute germany lisziewicz post doctoral research maxplanck institute experimental medicine lisziewicz worked national institutes health nih time working national cancer institute head antiviral unit laboratory tumor cell biology lisziewicz colleague franco lori founded research institute genetic human therapy right lisziewicz worked director right nonprofit organization based united states italy funds research develop immunologic technologies create new therapies research vaccines many chronic diseases like hivaids right strives quickly put discoveries use patient lisziewicz founded genetic immunity inc worked president ceo company genetic immunity private clinicalstage biotechnology company united states hungary genetic immunity works create commercialize immunotherapeutic biologics treat chronic viral infections allergies cancers prolong life patient improve quality treos bio company develops precision vaccines treat prevent cancer using computational immuneoncology lisziewicz worked chief scientific officer treos bio working national institute health lisziewicz worked find gene therapy approach treat hivaids based research discovering small portions genestopping dna called antisense oligonucleotides could created bind viral rna retroviruses like hiv virus could make copies continue infection small pieces messenger rna mrna carry copy cells dna ribosomes mrna directs ribosomes create proteins cells need viruses like hiv set mrna use ribosomes cell infected make new viruses propagate infection throughout body lisziewiczs idea create antisense oligonucleotides complementary hivs viral mrna complementary dna pieces bind hiv viral mrna prevent hiv virus replicating use antisense oligonucleotides worked well cell cultures quickly transferred clinical dermavir immunotherapy created lisziewiczs research national cancer institute bethesda maryland worked produce gene antisense therapies treat hivaids researched immune system controls hiv tissue culture monkey models applied results treatment hiv patients clinical trials lisziewicz discovered headed preclinical clinical development dermavir hiv immunotherapy lisziewiczs direction dermavir successfully completed phase clinical dermavir topical vaccine applied patch skin new immunization strategy uses dendritic cells increase viral antigen production dermavir contains plasmid expresses hiv proteins except integrase stimulates immune response attack cells infected hiv dermavir proven safe immunogenic several clinical trials one collaboration division aids daids one trial lisziewiczs research team compared immunogenicity topicalbased ex vivo dendritic cellbased dermavir rhesus macaques result discovered vaccinations induced helper cells memory cells specific simian immunodeficiency virus helper cells memory cells identified using vivo skin test vitro intracellular cytokinebased assay topical dermavir vaccine improvement upon ex vivo dendritic cell based immunization could offer new alternative therapy patients investigation lisziewicz involved working treos bio human leukocyte antigen hla genes regulate immune responses research led development computational immuneoncology technology determine patients natural cell response tumor antigens result treos bio found correlation patients hla gene sequence well immunotherapies worked immunotherapies treat number cancer indications created treos bio using computational immuneoncology langerhans cells natural agent antigen release precursors dendritic cells skin mucosa lisziewicz team developed synthetic nanoparticles act like pathogens specially target langerhans cells epidermal cell cultures nanoparticles applied topically human subjects strong immune response observed vaccine clinically proven opens door new dendritic celltargeting vaccines created treatment httpsenwikipediaorgwikijuliannalisziewicz